In Case You Missed It: Baltimore Running Festival photos
Business

U.Md. program awards $4.1 million to companies and faculty developing tech products

Aerospace ManufacturingManufacturing and EngineeringMedImmune Inc.Breast CancerLockheed Martin Corp.

A University of Maryland program that matches researchers with companies has awarded $4.1 million to 15 teams working to bring technology products to market.

Baltimore-area companies that will work with faculty through the Maryland Industrial Partnerships program include Columbia-based A&G Pharmaceutical Inc., which will receive $203,161 to conduct a clinical study on a blood test for early breast cancer screening, and Baltimore-based Rehabtics LLC, which is developing a software system for physical rehabilitation video games.

Other Baltimore-area projects include gene-silencing technology for a potential cancer therapy under development by Towson-based Birich Technologies LLC and Halethorpe-based Fiberight LLC's technology platform to convert organic municipal solid waste streams in to biofuels..

Faculty members from state universities throughout the state will work with 11 startups, three small firms and one medium-sized company. Other projects involve technologies for oyster-farming, green initiatives and Chesapeake Bay cleanup

Since 1987, the partnership program run through the university's A. James Clark School of Engineering in College Park has helped create products that generated $28.1 billion in revenue and more than 5,000 current jobs. Past recipients include MedImmune, Hughes Network Systems, Lockheed Martin and Northrop Grumman

The program, part of the university's Maryland Technology Enterprise Institute, is contributing $1.3 million while companies are contributing $2.8 million. Funding for this round also is coming from the Maryland Department of Natural Resources and the Environmental Protection Agency.

Lorraine.mirabella@baltsun.com

Copyright © 2014, The Baltimore Sun
Related Content
Aerospace ManufacturingManufacturing and EngineeringMedImmune Inc.Breast CancerLockheed Martin Corp.
Comments
Loading